Artificial Intelligence: Novartis And Microsoft Team Up to Transform Global Medicine

A collaboration between multinational pharmaceutical company Novartis and technological giant Microsoft aims to bring AI to the desk of every Novartis employee.

Novartis announced its plan for founding the Novartis AI innovation lab in collaboration with Microsoft as the AI and data-science partner. The Novartis-Microsoft alliance will “reimagine medicine” and boost Novartis’ AI capabilities. The new lab will discover and develop transformative medicine for patients globally.

Novartis-Microsoft alliance in multi-year R&D effort

The new lab will be the centerpiece of the collaboration and focus on a two-pronged objective.

‘AI Empowerment’ will make Novartis datasets and Microsoft’s AI solutions accessible to every Novartis associate.

‘AI Exploration’ will harness AI to tackle the most difficult computational challenges faced by the life sciences industry.

Further, the Novartis-Microsoft alliance will develop AI applications for future lab programs.

Microsoft AI

Microsoft AI helps transform business by driving innovation. It is already in use at The Hershey Company, NHS Glasgow and Clyde, BP, and Schneider Electric.

For example, Schneider developed a predictive analytics solution based on machine learning and IoT. Energy producers use it to monitor remote equipment — saving maintenance costs, optimizing production, and increasing safety for workers and the environment.

Also, Microsoft focused on transforming healthcare through AI and the cloud. Furthermore, the company announced the availability of the Microsoft Genomics service on Azure last year.

Meanwhile, Azure provides researchers, data scientists, and clinicians cloud-powered genomic processing services to handle huge data workloads.

Microsoft also launched last year the Azure Security and Compliance Blueprint: HIPAA/HITRUST – Health Data & AI provides a secure and automated environment to build applications that manage sensitive and regulated data.

Novartis-Microsoft alliance to reimagine medicine

Finally, the deal will likely bolster the development of new medicines.

“Pairing our deep knowledge of human biology and medicine with Microsoft’s leading expertise in AI could transform the way we discover and develop medicines for the world,” said Vas Narasimhan, CEO of Novartis.


Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.

Alt Insights

May 21, 2020

Venture Capital: British Startup Offers Travel Jaunts on the Never-Never

Venture Capital: British Startup Offers Travel Jaunts on the Never-Never

Latest Alternative Investment News
Private Equity: Coty Sells Majority Stake of Hair Business to KKR
June 1, 2020     News, Private Equity

Beauty products firm Coty (NASDAQ: COTY) and KKR (NYSE: KKR) have entered into a strategic transaction for Coty’s Professional and Retail Hair business. The transaction includes the Wella, Clairol, OPI…
Liquid Alternatives: AuM of Actively Managed ETFs Shows 36% Add Y-on-Y
June 1, 2020     Liquid Alternatives, News

Investors are increasingly interested in targeted strategies inside an ETF product. More than half of ETF launches thus far in 2020 have been actively managed ETFs, observed Yones on CNBC’s…
Digital Assets: China Merchants Aims To Be the First Blockchain-Powered Port in the World
June 1, 2020     Digital Assets, News

China Merchant’s Port (HKG: 0144), the country’s largest port operator, is collaborating with Alibaba Group (NYSE: BABA), and its subsidiary, Ant Financial to develop a distributed ledger technology (DLT), or…
Venture Capital: Startups Higi and Tock Raise Most of Chicago’s VC Haul of $68M in May
June 1, 2020     News, Venture Capital

According to data from Chicago Inno, tech, and start-up companies in Chicago raised approximately $ 68 million of venture capital during the month of May. At the top of the…

Scroll to Top